[Clinical experiments with a new oral anti-edema drug: nimesulide].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D004487:Edema / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D013449:Sulfonamides / Q000627:therapeutic use*; D014081:Tooth Extraction / Q000009:adverse effects*; D014095:Tooth, Impacted / Q000601:surgery
D000893:Anti-Inflammatory Agents; D013449:Sulfonamides; D010447:Peptide Hydrolases; C022640:serratiopeptidase; C012655:nimesulide
Sperimentazione clinica di un nuovo antiedemigeno orale: "nimesulide".